72 related articles for article (PubMed ID: 3319137)
1. Reversible central nervous system toxicity associated with high-dose chlorambucil in autologous bone marrow transplantation for ovarian carcinoma.
Ciobanu N; Runowicz C; Gucalp R; Frank M; Charuvanki V; Kaufman D; Wiernik PH
Cancer Treat Rep; 1987 Dec; 71(12):1324-5. PubMed ID: 3319137
[No Abstract] [Full Text] [Related]
2. Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma.
Lotz JP; Bouleuc C; André T; Touboul E; Macovei C; Hannoun L; Lefranc JP; Houry S; Uzan S; Izrael V
Cancer; 1996 Jun; 77(12):2550-9. PubMed ID: 8640705
[TBL] [Abstract][Full Text] [Related]
3. Salvage therapy for recurrent and refractory ovarian cancer with high-dose chemotherapy and autologous bone marrow support: a Gynecologic Oncology Group pilot study.
Broun ER; Belinson JL; Berek JS; McIntosh D; Hurd D; Ball H; Williams S
Gynecol Oncol; 1994 Aug; 54(2):142-6. PubMed ID: 8063237
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy with autologous bone marrow support in ovarian carcinoma: the bottom line, more or less.
Thigpen T
Gynecol Oncol; 1995 Jun; 57(3):275-7. PubMed ID: 7774829
[No Abstract] [Full Text] [Related]
5. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
[TBL] [Abstract][Full Text] [Related]
6. [High dose chemotherapy with autologous bone marrow transplantation in ovarian adenocarcinoma].
Extra JM; Cure H; Viens P; Maraninchi D; Legros M; Marty M
Bull Cancer; 1993 Feb; 80(2):156-62. PubMed ID: 8173168
[TBL] [Abstract][Full Text] [Related]
7. Future strategies for the treatment of advanced epithelial ovarian cancer using high-dose chemotherapy and autologous bone marrow support.
Shpall EJ; Jones RB; Bearman SI; Purdy MP
Gynecol Oncol; 1994 Sep; 54(3):357-61. PubMed ID: 8088613
[TBL] [Abstract][Full Text] [Related]
8. [Study of autologous bone marrow transplantation in the treatment of gynecologic carcinoma].
Tu C; Meng Y; Lin Y
Zhonghua Fu Chan Ke Za Zhi; 1995 Aug; 30(8):475-8. PubMed ID: 8565695
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.
Motzer RJ; Gulati SC; Tong WP; Menendez-Botet C; Lyn P; Mazumdar M; Vlamis V; Lin S; Bosl GJ
Cancer Res; 1993 Aug; 53(16):3730-5. PubMed ID: 8393380
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of malignant ovarian tumors.
Murakami M; Shinozuka T; Kuroshima Y; Tokuda Y; Tajima T
Semin Oncol; 1994 Feb; 21(1 Suppl 1):29-32. PubMed ID: 8153654
[No Abstract] [Full Text] [Related]
11. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin neurotoxicity in patients treated with allogeneic bone marrow transplantation.
Labar B; Bogdanic V; Plavsic F; Francetic I; Dobric I; Kastelan A; Grgicevic D; Vrtar M; Grgic-Markulin L; Balabanic-Kamauf B
Biomed Pharmacother; 1986; 40(4):148-50. PubMed ID: 3539218
[TBL] [Abstract][Full Text] [Related]
13. [Secondary myelodysplastic syndrome].
Shammas FV; Heikkilä R
Tidsskr Nor Laegeforen; 1997 Nov; 117(29):4220-2. PubMed ID: 9441464
[TBL] [Abstract][Full Text] [Related]
14. [Autologous bone marrow transplantation in the postoperative chemotherapy using high doses of Eudoxan in cancer patients].
Stoitschkov K; Iliev G
Z Gesamte Inn Med; 1966 Nov; 21(21):Suppl:280-1. PubMed ID: 4869840
[No Abstract] [Full Text] [Related]
15. Pilot study of high-dose mitoxantrone and busulfan plus autologous bone transplantation in patients with advanced malignancies.
Khalil A; Ciobanu N; Sparano JA; Gucalp R; Dutcher JP; Wiernik PH
Bone Marrow Transplant; 1995 Jan; 15(1):93-7. PubMed ID: 7742763
[TBL] [Abstract][Full Text] [Related]
16. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
[TBL] [Abstract][Full Text] [Related]
17. [Chlorambucil pulse therapy in progressive chronic polyarthritis. Initial results of an open multicenter study].
Aeschlimann A; Brackertz D; Kaiser H; Müller W
Z Rheumatol; 1987; 46(5):241-4. PubMed ID: 3321755
[TBL] [Abstract][Full Text] [Related]
18. [Autologous bone marrow transplantation in the treatment of nasopharyngeal carcinoma--report of 2 cases].
Odaka K; Fujimura M; Yoshida T; Ohtake S; Teshima H; Shiobara S; Matsue K; Ishino C; Funada H; Nakamura S; Hattori K; Harada M
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):245-53. PubMed ID: 6349532
[TBL] [Abstract][Full Text] [Related]
19. [Hematopoiesis after autotransplantation of preserved bone marrow in patients receiving chemotherapy].
Lavrik SS; Baksheeva AA; Zverkova AS
Vrach Delo; 1965 Dec; 12():61-5. PubMed ID: 5334559
[No Abstract] [Full Text] [Related]
20. Constant intravenous pentoxifylline infusions in allogeneic marrow transplant recipients: results of a dose escalation study.
Beelen DW; Sayer HG; Franke M; Scheulen ME; Quabeck K; Mohnke M; Oidtmann M; Schaefer UW
Bone Marrow Transplant; 1993 Oct; 12(4):363-70. PubMed ID: 8275036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
